ebook Munafa Stock Market Course + Intraday & FNO calls  

       

ORCHIDPHAR announcements Orchid Pharma Limited announcements and dividends declared NSE

Orchid Pharma Limited Complete list of announcements declared & dividend announcements by Orchid Pharma Limited ORCHIDPHAR

Orchid Pharma Limited ORCHIDPHAR listed on NSE and deals in

Announcements and dividends declared by Orchid Pharma Limited ORCHIDPHAR

Orchid Pharma receives USFDA approval for Enmetazobactam
Orchid Pharma has received approval by the United States Food and Drug Administration (USFDA) for its novel invention, Enmetazobactam'. This development comes in close succession to the recent recommendation for approval by the European Medicines Agency (E
Announcement as on 23 February 2024

Orchid Pharma jumps after receiving USFDA nod for Exblifep injections
Orchid Pharma rallied 5.76% to Rs 1,217.20 after the company has received an approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Exblifep(Cefepime and Enmetazobactam injections).
Announcement as on 23 February 2024

Orchid Pharma's new antibiotic 'Exblifeb' gets European Medicines Agency approval
The Chennai-based firm said Exblifeb incorporates Enmetazobactam, "the first completely invented-in-India Beta Lactamase inhibitor" and it is designed to address the global challenge of antimicrobial resistance (AMR). Exblifeb' demonstrates remarkable effi
Announcement as on 30 January 2024

Orchid Pharma enter tech transfer pact to make key cephalosporin intermediate
Chennai-based drug maker, Orchid Pharma, has signed a technology transfer agreement with a multinational biotechnology company, for its 7ACA project under the production linked incentive (PLI) scheme. The deal will enable Orchid Bio Pharma to manufacture "
Announcement as on 11 July 2023

Orchid Pharma locked in upper circuit, QIP floor price set at Rs 425
Sources have told CNBC-TV18 that the base size for the issue is approximately Rs 300 crore, with an option to upsize up to Rs 400 crore
Announcement as on 23 June 2023

Announcements by Orchid Pharma Limited first page | Next page | Prev page |

ORCHIDPHAR Orchid Pharma Limited current price & indicator signals

Moving Averages for Orchid Pharma Limited

  • 5Day Average: 6.76
  • 12Day Average: 7.28
  • 20Day Average: 7.41
  • 50Day Average: 9.55
  • 100Day Average: 12.93
  • 150Day Average: 14.9
  • 200Day Average: 15.83

ORCHIDPHAR Indicators & signals

Indicator MACD (12,26,9)

7.13, 7.93, -0.81
Indicator MACD is in negative zone

Indicator ADX (14)

53.33, 11.11, 36.51
Indicator ADX is indicating that momentum is still strong.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 42
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of ORCHIDPHAR Orchid Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
19 Fri Oct 2018 5.60 5.50 to 5.70 -21.13% 0.4 times
08 Fri Jun 2018 7.10 6.65 to 7.20 2.16% 0.79 times
07 Thu Jun 2018 6.95 6.80 to 7.15 -2.8% 1.54 times
06 Wed Jun 2018 7.15 6.80 to 7.25 2.14% 0.76 times
05 Tue Jun 2018 7.00 7.00 to 7.50 -4.76% 1.38 times
04 Mon Jun 2018 7.35 7.30 to 7.90 -3.92% 0.54 times
01 Fri Jun 2018 7.65 7.25 to 7.90 0.66% 0.46 times
31 Thu May 2018 7.60 7.50 to 8.20 -3.18% 0.56 times
30 Wed May 2018 7.85 7.75 to 8.10 -1.26% 0.32 times
29 Tue May 2018 7.95 7.40 to 8.10 2.58% 2.64 times
28 Mon May 2018 7.75 7.65 to 7.80 4.03% 1 times
25 Fri May 2018 7.45 7.20 to 7.60 2.76% 0.48 times

Videos related to: ORCHIDPHAR announcements Orchid Pharma Limited announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

ORCHIDPHAR announcements Orchid Pharma Limited announcements and dividends declared NSE

 

Back to top